Differences in EQ-5D-3L health state valuations among patients with musculoskeletal diseases, health care professionals and healthy volunteers
Publikation: Beiträge in Zeitschriften › Zeitschriftenaufsätze › Forschung › begutachtet
Standard
in: The European journal of health economics, Jahrgang 16, Nr. 8, 01.11.2015, S. 865-877.
Publikation: Beiträge in Zeitschriften › Zeitschriftenaufsätze › Forschung › begutachtet
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Differences in EQ-5D-3L health state valuations among patients with musculoskeletal diseases, health care professionals and healthy volunteers
AU - Schwalm, Anja
AU - Feng, You Shan
AU - Moock, Jörn
AU - Kohlmann, Thomas
PY - 2015/11/1
Y1 - 2015/11/1
N2 - Background: Results from existing studies indicate that different respondent groups’ health state valuations in cost-utility analyses are not equivalent. Objectives: The objectives in our study were to analyse differences in health state valuations among three respondent groups in the context of medical rehabilitation in Germany. Methods: Using the time trade-off (TTO) technique, valuations of EQ-5D-3L health states were obtained from patients with musculoskeletal diseases, healthy volunteers and health care professionals. We used linear mixed models to predict TTO utilities and specified and tested interaction effects. Results: We identified statistically significant (p < 0.05) differences among the three groups in six out of 42 health states. On average, patients’ TTO values were somewhat higher compared with other respondent groups. Most of these differences occurred in severe health states. Mean differences and mean absolute differences were 0.02 and 0.14 for patients vs healthy volunteers and 0.06 and 0.14 for patients vs health care professionals. Furthermore, significant effects among respondents were observed for seven of the 22 possible interactions describing differences between respondent groups. Coefficients associated with significant interaction effects ranged from 0.08 to 0.18 (absolute values). Conclusion: The results of our study suggest that TTO valuations of health states differ depending on the specific respondent group from which valuations are obtained. On average, these differences were small. However, researchers and decision makers should remain aware of these differences when interpreting incremental cost-utility assessments.
AB - Background: Results from existing studies indicate that different respondent groups’ health state valuations in cost-utility analyses are not equivalent. Objectives: The objectives in our study were to analyse differences in health state valuations among three respondent groups in the context of medical rehabilitation in Germany. Methods: Using the time trade-off (TTO) technique, valuations of EQ-5D-3L health states were obtained from patients with musculoskeletal diseases, healthy volunteers and health care professionals. We used linear mixed models to predict TTO utilities and specified and tested interaction effects. Results: We identified statistically significant (p < 0.05) differences among the three groups in six out of 42 health states. On average, patients’ TTO values were somewhat higher compared with other respondent groups. Most of these differences occurred in severe health states. Mean differences and mean absolute differences were 0.02 and 0.14 for patients vs healthy volunteers and 0.06 and 0.14 for patients vs health care professionals. Furthermore, significant effects among respondents were observed for seven of the 22 possible interactions describing differences between respondent groups. Coefficients associated with significant interaction effects ranged from 0.08 to 0.18 (absolute values). Conclusion: The results of our study suggest that TTO valuations of health states differ depending on the specific respondent group from which valuations are obtained. On average, these differences were small. However, researchers and decision makers should remain aware of these differences when interpreting incremental cost-utility assessments.
KW - Health sciences
KW - Quality-adjusted life years
KW - Patient preference
KW - Health status
KW - Quality of life
KW - Cost effectiveness
UR - http://www.scopus.com/inward/record.url?scp=84944158118&partnerID=8YFLogxK
U2 - 10.1007/s10198-014-0636-y
DO - 10.1007/s10198-014-0636-y
M3 - Journal articles
C2 - 25283996
VL - 16
SP - 865
EP - 877
JO - The European journal of health economics
JF - The European journal of health economics
SN - 1618-7598
IS - 8
ER -